ONESOURCENSEOnesource Specialty Pharma LimitedMediumNeutral
Announced Wed, 31 Dec · 19:34 IST

Onesource Specialty Pharma Limited has informed the Exchange regarding 'Intimation of Press Release done by the Credit Rating Agency'.

New Credit FacilityCredit & Debt View source PDF

ONESOURCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

OneSource Specialty Pharma has informed the stock exchanges that India Ratings & Research (Ind-Ra) has affirmed a credit rating of IND A- with a Positive outlook for the company's additional bank loan facilities. This rating is consistent with the previous rating assigned on June 3, 2025. IND A- indicates adequate debt-servicing capacity with some vulnerability to business and economic conditions, while the Positive outlook suggests a possible rating upgrade in the future.

Likely market impact

The rating affirmation at IND A-/Positive is a stable-to-slightly-positive signal for shareholders, indicating the rating agency sees continued creditworthiness and possible improvement. The rating specifically covers additional bank loan facilities, suggesting fresh borrowings have been rated at investment grade.